FDA grants 510(k) clearance to chest X-ray triage software healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
With the FDA clearance, the company is now able to commercially provide the AI solution to medical professionals and healthcare institutions in the U.S.
/PRNewswire/ Bering Limited, a London-based medical AI company, today announced it received US Food and Drug Administration (FDA) 510(k) clearance for its.
Media release: The Times and Sunday Times Scotland to host Life Sciences Summit in Aberdeen - allmediascotland…media jobs, media release service and media resources for all allmediascotland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from allmediascotland.com Daily Mail and Mail on Sunday newspapers.
AN international team including researchers from the University of Edinburgh has been awarded €750,000 (£690,000) to develop artificial intelligence (AI) diagnostic tools for liver disease. The project will look at ways of interpreting patient data to predict when non-alcoholic fatty liver disease (NAFLD) is likely to progress into dangerous conditions such as cirrhosis of the liver and liver cancer. Professor Jonathan Fallowfield and Dr Tim Kendall, from Edinburgh’s Centre for Inflammation Research, will work with a specialist imaging company based in Singapore and two British firms specialising in data management and AI techniques. Around a quarter of people have NAFLD, which affects millions of people worldwide and which is often unnoticed and undiagnosed. There is no way of telling which people with the disease might develop the severe form or progress to cirrhosis.